NewsRx

Search our medical news database

Healthcare Costs

BioSphere provides update on reimbursement for uterine fibroid embolization procedure

Published in Health Insurance Week, December 31st, 2006

BioSphere Medical, Inc., (BSMD) a medical device company that pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations, provided an update on physician reimbursement for the uterine fibroid embolization procedure (UFE).

On November 1, 2006, the Centers for Medicare and Medicaid Services (CMS) issued its preliminary rule providing for a single, all-inclusive Category I CPT code for UFE. Assuming that this preliminary rule becomes final as written, starting in 2007 a new CPT code will be designated for UFE, which is inclusive of all services occurring on the day of the procedure. The new physician...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Insurance Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook